Immuno-Oncology: Execs Talk About Tumor Response, Biomarkers, Lessons Learned
Executive Summary
Leaders from Novartis and other companies developing cellular gene therapies share insights they've gleaned on manufacturing, clinical trials, and value-based pricing.